<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns:ifp="http://www.ifactory.com/press" xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9">
  <ifp:contentType>ARTICLE</ifp:contentType>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-p499.xml</sm:loc>
    <ifp:title>Reducing Costs by Changing Behavior—Really?</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-p501.xml</sm:loc>
    <ifp:title>Defining Borderline Resectable Pancreatic Cancer: Emerging Consensus for an Old Challenge</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-p505.xml</sm:loc>
    <ifp:title>The Rodger Winn Award</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-p508.xml</sm:loc>
    <ifp:title>Sorafenib in Relapsed AML With FMS-Like Receptor Tyrosine Kinase-3 Internal Tandem Duplication Mutation</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-p515.xml</sm:loc>
    <ifp:title>Non–Small Cell Lung Cancer, Version 6.2015</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-p525.xml</sm:loc>
    <ifp:title>Use of Postprostatectomy Radiation Therapy at an NCI-Designated Comprehensive Cancer Center</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-p531.xml</sm:loc>
    <ifp:title>Omission of Adjuvant Therapy After Gastric Cancer Resection: Development of a Validated Risk Model</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-p543.xml</sm:loc>
    <ifp:title>Diagnostic Delays Are Common Among Patients With Hepatocellular Carcinoma</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-p554.xml</sm:loc>
    <ifp:title>Hodgkin Lymphoma, Version 2.2015</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-p587.xml</sm:loc>
    <ifp:title>Biologic Agents in the Management of Hodgkin Lymphoma</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-p597.xml</sm:loc>
    <ifp:title>Contemporary Radiation Therapy in Combined Modality Therapy for Hodgkin Lymphoma</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-p607.xml</sm:loc>
    <ifp:title>The Need for United States–Based Guidelines for Myeloproliferative Neoplasms</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-plv.xml</sm:loc>
    <ifp:title>Oncology Research Program</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-pxxvii.xml</sm:loc>
    <ifp:title>NCCN News</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-pe29.xml</sm:loc>
    <ifp:title>Management of the Primary Tumor and Limited Metastases in Patients With Metastatic Pancreatic Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5/article-pe37.xml</sm:loc>
    <ifp:title>Systemic Therapy for Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p611.xml</sm:loc>
    <ifp:title>20 Years of Advancing the Standard of Cancer Care</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p619.xml</sm:loc>
    <ifp:title>Abstracts From the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p629.xml</sm:loc>
    <ifp:title>NCCN: 20 Years of Improving Patients' Lives</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p640.xml</sm:loc>
    <ifp:title>NCCN Roundtable: What Are the Characteristics of an Optimal Clinical Practice Guideline?</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p643.xml</sm:loc>
    <ifp:title>New NCCN Guidelines: Smoking Cessation for Patients With Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p646.xml</sm:loc>
    <ifp:title>Toward Less-Invasive Management of Early-Stage Breast Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p649.xml</sm:loc>
    <ifp:title>Optimizing Treatment of HER2-Positive Breast Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p652.xml</sm:loc>
    <ifp:title>Evolving Treatment Strategies for Triple-Negative Breast Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p655.xml</sm:loc>
    <ifp:title>Advanced Hormone-Sensitive Breast Cancer: Overcoming Resistance</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p659.xml</sm:loc>
    <ifp:title>NCCN Roundtable:Value-Based Decision-Making at the Bedside</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p662.xml</sm:loc>
    <ifp:title>Updates to the Management of Chronic Lymphocytic Leukemia</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p666.xml</sm:loc>
    <ifp:title>Emerging Treatment Options for B-Cell Lymphomas</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p670.xml</sm:loc>
    <ifp:title>Principles of Immunotherapy</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p673.xml</sm:loc>
    <ifp:title>Treatment Options Expanding for Advanced Melanoma</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p676.xml</sm:loc>
    <ifp:title>Targeted/Emerging Therapies for Metastatic Non–Small Cell Lung Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p679.xml</sm:loc>
    <ifp:title>Kidney Cancer: Current and Novel Treatment Options</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p682.xml</sm:loc>
    <ifp:title>Optimizing Systemic Therapy Selection in Metastatic Colorectal Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p686.xml</sm:loc>
    <ifp:title>Management of Dermatologic Toxicities</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p690.xml</sm:loc>
    <ifp:title>New Treatment Options in Castration-Resistant Prostate Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p694.xml</sm:loc>
    <ifp:title>Multiple Myeloma: New Uses for Available Agents, Excitement for the Future</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p697.xml</sm:loc>
    <ifp:title>Treatment Milestones in Chronic Myelogenous Leukemia: Stay the Course or Change Therapy?</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-p700.xml</sm:loc>
    <ifp:title>Multidisciplinary Management of Pancreatic Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/13/5S/article-pe65.xml</sm:loc>
    <ifp:title>Additional Abstracts from the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
</urlset>
